Search

Inactivating a gene in young songbirds that’s closely linked with autism spectrum disorder (ASD) prevents the birds from forming memories necessary to accurately reproduce their fathers’ songs, a new study led by UT Southwestern shows.

Certain chemotherapies are associated with an increased long-term risk of subsequent tumors in survivors of childhood cancer, according to a study led by researchers at UT Southwestern Medical Center.

Early in his career, Ralf Kittler, Ph.D., attracted the attention of academic leaders at UT Southwestern Medical Center with his studies of DNA transcription factors and their role in tumor growth and suppression.

Jean-Laurent Casanova, M.D., Ph.D., an internationally recognized expert in the fields of genetics, immunology, and infectious diseases who will be joining UT Southwestern Medical Center on July 1, has been selected along with a global team of researchers to receive a Cancer Grand Challenges award of up to $25 million.

Sahoo Collaborates in Study of Single-Dose Radiation to Eradicate Breast Cancer Published on: November 17, 2025 Single-dose radiation before surgery can eradicate breast cancer Back-to top

Kapur and Hein Develop AI System to Improve Data Collection Published on: July 28, 2025 UTSW builds AI-driven system to improve data collection Back-to top

UTSW researchers say findings are a first step toward more targeted treatments for millions of people with allergies

UT Southwestern Medical Center researchers have identified two lipids that work together with a quintessential protein known as stimulator of interferon genes (STING) to launch an immune response in the human body.

KRAS is the most frequently mutated oncogene across all human cancers. Although different KRAS mutations have long been thought to exert the same cancer-driving effects, a new study led by UT Southwestern Medical Center researchers suggests that different KRAS mutation types can variously impact how cancer cells interact with immune cells, significantly affecting the malignant cells’ behavior.

UT Southwestern Medical Center researchers have discovered that increasing the levels of a protein called BACH2 makes engineered cancer-fighting immune cells behave more like stem cells, improving their therapeutic effectiveness.